ea0092op-10-03 | Oral Session 10: Novel diagnostics in Thyroid cancer | ETA2023
Prinzi Antonio
, Bosco Agata
, Mirone Alessandro
, Tumino Dario
, Di Benedetto Guenda
, Gambero Federica
, Bartoloni Giovanni
, Frasca Francesco
, Belfiore Antonino
, Malandrino Pasqualino
Background: The 2022 WHO Classification of Endocrine and Neuroendocrine Tumors has introduced, as other neuroendocrine neoplasms, new pathological features to classify medullary thyroid carcinoma (MTC) in low/high grade. However, whether it can be reliable in clinical practice should be confirm by further studies.Aim: To verify the predictive value of the 2022 WHO grading system in patients with MTC.Materials and Methods: Tumor tis...